Heart Failure Association-International Cardio-Oncology Society Risk Score Validation in HER2-Positive Breast Cancer.
Michael CroninAileen CrowleyMatthew G DaveyPeter RyanMahmoud AbdelshafyAhmed ElkoumyHesham ElzomorShahram Arsang-JangSandra GanlyPatrick NashJames CrowleyFaisal SharifAndrew SimpkinAoife LoweryWilliam WijnsMichael KerinJuan Carlos ParodiPublished in: Journal of clinical medicine (2023)
The HFA-ICOS risk score has moderate power in predicting cancer therapy-related cardiotoxicity in HER2-positive breast cancer patients.